Login Register Cart 0
Generic placeholder image

Current Nutrition & Food Science

Editor-in-Chief

ISSN (Print): 1573-4013
ISSN (Online): 2212-3881

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Could Microbiota Edit Oxalate Nephrolithiasis’ Story?

Author(s): Giuseppe Merra, Paola Gualtieri*, Antonino De Lorenzo, Annunziata Capacci, Giulia Frank, Maria Dri, Laura Di Renzo and Marco Marchetti

Volume 20, Issue 3, 2024

Published on: 13 June, 2023

Page: [271 - 282] Pages: 12

DOI: 10.2174/1573401319666230601143942

Next »
[1]
Ferraro PM, Curhan GC, D’Adessi A, et al. Risk of recurrence of idiopatica calcium kidney stones: Analisys of data from the literature. J Nephrol 2017; 30(2): 227-33.
[PMID: 26969574]
[2]
Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant 2008; 24(1): 130-6.
[http://dx.doi.org/10.1093/ndt/gfn420] [PMID: 18662977]
[3]
Bushinsky DA. Renal lithiasis. Kelly' s Textbook of Medicine. 1996; pp. 1024-8.
[4]
Asplin JR, Favus MJ, Coe FL. Nephrolithiasis In: The Kidney. 1996; pp. 1893-935.
[5]
Pearle MS, Calhoun EA, Curhan GC. Urologic diseases in America project: Urolithiasis. J Urol 2005; 173(3): 848-57.
[http://dx.doi.org/10.1097/01.ju.0000152082.14384.d7] [PMID: 15711292]
[6]
Andreoli TE, Bennet JC, Carpenter C. Cecil's compendium of internal medicine. Roma: Verduci editore. 1998.
[7]
Gambaro G, Croppi E, Coe F, et al. Metabolic diagnosis and medical prevention of calcium nephrolithiasis and its systemic manifestations: A consensus statement. J Nephrol 2016; 29(6): 715-34.
[http://dx.doi.org/10.1007/s40620-016-0329-y] [PMID: 27456839]
[8]
Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest 2005; 115(10): 2598-608.
[http://dx.doi.org/10.1172/JCI26662] [PMID: 16200192]
[9]
Pak CYC, Skurla C, Harvey J. Graphic display of urinary risk factors for renal stone formation. J Urol 1985; 134(5): 867-70.
[http://dx.doi.org/10.1016/S0022-5347(17)47496-9] [PMID: 4057368]
[10]
Yaqoob M. Calculi and nephrocalcinosis. Medicina clinica Roma: Cic International Editions. 2007.
[11]
Fleisch H. Inhibitors and promoters of stone formation. Kidney Int 1978; 13(5): 361-71.
[http://dx.doi.org/10.1038/ki.1978.54] [PMID: 351264]
[12]
Griffith DP, Osborne CA. Infection (urease) stones. Miner Electrolyte Metab 1987; 13(4): 278-85.
[PMID: 3306321]
[13]
Keefe WE, Smith MJ. Intracellular crystalline deposits by bacteria grown in urine from a stone former. Invest Urol 1977; 14(5): 344-6.
[PMID: 844994]
[14]
Robertson WJ, Peacock M. Epidemiological factors in the genesis of calcium-containing urinary stones. Metabolic, Physico-chemical, Therapeutical aspects of urolithiasis 1981; 5-20.
[15]
Fan J, Chandhoke PS, Grampsas SA. Role of sex hormones in experimental calcium oxalate nephrolithiasis. J Am Soc Nephrol 1999; 10 (Suppl. 14): S376-80.
[PMID: 10541267]
[16]
Nordin BEC, Peacock M, Wilkinson R. Hypercalciuria and calcium stone disease. Clin Endocrinol Metab 1972; 1(1): 169-83.
[http://dx.doi.org/10.1016/S0300-595X(72)80055-0]
[17]
Curhan GC, Willett WC, Rimm EB, Speizer FE, Stampfer MJ. Body size and risk of kidney stones. J Am Soc Nephrol 1998; 9(9): 1645-52.
[http://dx.doi.org/10.1681/ASN.V991645] [PMID: 9727373]
[18]
Curhan GC, Willett WC, Rimm EB, Stampfer MJ. Family history and risk of kidney stones. J Am Soc Nephrol 1997; 8(10): 1568-73.
[http://dx.doi.org/10.1681/ASN.V8101568] [PMID: 9335385]
[19]
Sakhaee K, Maalouf NM, Sinnott B. Clinical review. Kidney stones 2012: Pathogenesis, diagnosis, and management. J Clin Endocrinol Metab 2012; 97(6): 1847-60.
[http://dx.doi.org/10.1210/jc.2011-3492] [PMID: 22466339]
[20]
Borghi L, Meschi T, Amato F, Novarini A, Romanelli A, Cigala F. Hot occupation and nephrolithiasis. J Urol 1993; 150(6): 1757-60.
[http://dx.doi.org/10.1016/S0022-5347(17)35887-1] [PMID: 8230496]
[21]
Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13 (Suppl. 3): S45-50.
[PMID: 11132032]
[22]
Bleich HL, Boro ES, Coe FL, Kavalach AG. Hypercalciuria and hyperuricosuria in patients with calcium nephrolithiasis. N Engl J Med 1974; 291(25): 1344-50.
[http://dx.doi.org/10.1056/NEJM197412192912510] [PMID: 4610395]
[23]
Asplin JR. Hyperoxaluric calcium nephrolithiasis. Endocrinol Metab Clin North Am 2002; 31(4): 927-49.
[http://dx.doi.org/10.1016/S0889-8529(02)00030-0] [PMID: 12474639]
[24]
Marengo SR, Romani AMP. Oxalate in renal stone disease: The terminal metabolite that just won’t go away. Nat Clin Pract Nephrol 2008; 4(7): 368-77.
[http://dx.doi.org/10.1038/ncpneph0845] [PMID: 18523430]
[25]
Robertson WG, Scurr DS, Bridge CM. Factors influencing crystallization of calcium oxalate in urine: A critique. J Crystal Growth 1981; 53: 182.
[26]
Marshall RW, Cochran M, Hodgkinson A. Relationships between calcium and oxalic acid intake in the diet and their excretion in the urine of normal and renal-stone-forming subjects. Clin Sci 1972; 43(1): 91-9.
[http://dx.doi.org/10.1042/cs0430091] [PMID: 5040764]
[27]
Jaeger P, Portmann L, Jacquet AF, Burckhardt P. Influence of the calcium content of the diet on the incidence of mild hyperoxaluria in idiopathic renal stone formers. Am J Nephrol 1985; 5(1): 40-4.
[http://dx.doi.org/10.1159/000166901] [PMID: 3970077]
[28]
Barilla DE, Notz C, Kennedy D, Pak CYC. Renal oxalate excretion following oral oxalate loads in patients with ileal disease and with renal and absorptive hypercalciurias. Am J Med 1978; 64(4): 579-85.
[http://dx.doi.org/10.1016/0002-9343(78)90576-4] [PMID: 645724]
[29]
Ito H, Suzuki F, Yamaguchi K, Nishikawa Y, Kotake T. Reduction of urinary oxalate by combined calcium and citrate administration without increase in urinary calcium oxalate stone formers. Clin Nephrol 1992; 37(1): 14-8.
[PMID: 1541059]
[30]
Finkielstein VA, Goldfarb DS. Strategies for preventing calcium oxalate stones. CMAJ 2006; 174(10): 1407-9.
[http://dx.doi.org/10.1503/cmaj.051517] [PMID: 16682705]
[31]
Nishiura JL, Martini LA, Mendonça COG, Schor N, Heilberg IP. Effect of calcium intake on urinary oxalate excretion in calcium stone-forming patients. Braz J Med Biol Res 2002; 35(6): 669-75.
[http://dx.doi.org/10.1590/S0100-879X2002000600006] [PMID: 12045831]
[32]
Coe FL. Hyperuricosuric calcium oxalate nephrolithiasis. Kidney Int 1978; 13(5): 418-26.
[http://dx.doi.org/10.1038/ki.1978.60] [PMID: 661071]
[33]
Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Twenty-four–hour urine chemistries and the risk of kidney stones among women and men. Kidney Int 2001; 59(6): 2290-8.
[http://dx.doi.org/10.1046/j.1523-1755.2001.00746.x] [PMID: 11380833]
[34]
Domrongkitchaiporn S, Stitchantrakul W, Kochakarn W. Causes of hypocitraturia in recurrent calcium stone formers: Focusing on urinary potassium excretion. Am J Kidney Dis 2006; 48(4): 546-54.
[http://dx.doi.org/10.1053/j.ajkd.2006.06.008] [PMID: 16997050]
[35]
Curhan GC, Willet WC. A prospective study of dietary calcium and other nutrients and the risk of symptomatic kidney stone. The New England J Med 1993; 12(833): 838.
[36]
Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: New insights after 14 years of follow-up. J Am Soc Nephrol 2004; 15(12): 3225-32.
[http://dx.doi.org/10.1097/01.ASN.0000146012.44570.20] [PMID: 15579526]
[37]
Robertson WG, Peacock M, Marshall DH. Prevalence of urinary stone disease in vegetarians. Eur Urol 1982; 8(6): 334-9.
[http://dx.doi.org/10.1159/000473551] [PMID: 7140784]
[38]
Meschi T, Maggiore U, Fiaccadori E, et al. The effect of fruits and vegetables on urinary stone risk factors. Kidney Int 2004; 66(6): 2402-10.
[http://dx.doi.org/10.1111/j.1523-1755.2004.66029.x] [PMID: 15569332]
[39]
Siener R, Hesse A. The effect of different diets on urine composition and the risk of calcium oxalate crystallisation in healthy subjects. Eur Urol 2002; 42(3): 289-96.
[http://dx.doi.org/10.1016/S0302-2838(02)00316-0] [PMID: 12234515]
[40]
Sakhaee K, Harvey JA, Padalino PK, Whitson P, Pak CYC. The potential role of salt abuse on the risk for kidney stone formation. J Urol 1993; 150(2 Part 1): 310-2.
[http://dx.doi.org/10.1016/S0022-5347(17)35468-X] [PMID: 8326549]
[41]
Frassetto LA, Morris RC Jr, Sellmeyer DE, Sebastian A. Adverse effects of sodium chloride on bone in the aging human population result-ing from habitual consumption of typical American diets. J Nutr 2008; 138(2): 419S-22S.
[http://dx.doi.org/10.1093/jn/138.2.419S] [PMID: 18203914]
[42]
Nouvenne A, Meschi T, Prati B, et al. Effects of a low-salt diet on idiopathic hypercalciuria in calcium-oxalate stone formers: A 3-mo randomized controlled trial. Am J Clin Nutr 2010; 91(3): 565-70.
[http://dx.doi.org/10.3945/ajcn.2009.28614] [PMID: 20042524]
[43]
Donfrancesco C, Ippolito R. A simple method to estimate population 24-h urinary intake in Italy: Results of the MINISAL study. Nutr Metab Cardiovasc Dis 2012; 16: 97-103.
[44]
Sebastian RS, Wilkinson Enns C, Steinfeldt LC, Goldman JD, Moshfegh AJ. Monitoring sodium intake of the US population: Impact and implications of a change in what we eat in America, National Health and Nutrition Examination Survey dietary data processing. J Acad Nutr Diet 2013; 113(7): 942-9.
[http://dx.doi.org/10.1016/j.jand.2013.02.009] [PMID: 23567248]
[45]
Pak CYC. Medical management of nephrolithiasis in Dallas: Update 1987. J Urol 1988; 140(3): 461-7.
[http://dx.doi.org/10.1016/S0022-5347(17)41692-2] [PMID: 3045339]
[46]
Coe FL, Favus MJ, Crockett T, et al. Effects of low-calcium diet on urine calcium excretion, parathyroid function and serum 1,25(OH)2D3 levels in patients with idiopathic hypercalciuria and in normal subjects. Am J Med 1982; 72(1): 25-32.
[http://dx.doi.org/10.1016/0002-9343(82)90567-8] [PMID: 6277190]
[47]
Curhan GC, Willett WC, Speizer FE, et al. Comparison of dietary calcium with supplemental calcium and other nutrients as factors affect-ing the risk for kidney stones in women. Ann Internal Med 1997; 126: 497-504.
[48]
Borghi L, Schianchi T, Meschi T, et al. Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria. N Engl J Med 2002; 346(2): 77-84.
[http://dx.doi.org/10.1056/NEJMoa010369] [PMID: 11784873]
[49]
Meschi T, Nouvenne A, Ticinesi A, et al. Dietary habits in women with recurrent idiopathic calcium nephrolithiasis. J Transl Med 2012; 10(1): 63.
[http://dx.doi.org/10.1186/1479-5876-10-63] [PMID: 22453026]
[50]
Nguyen QV, Kälin A, Drouve U, Casez JP, Jaeger P. Sensitivity to meat protein intake and hyperoxaluria in idiopathic calcium stone for-mers. Kidney Int 2001; 59(6): 2273-81.
[http://dx.doi.org/10.1046/j.1523-1755.2001.00744.x] [PMID: 11380831]
[51]
Baxmann AC, De OG, Mendonça C, Heilberg IP, Heilberg IP. Effect of vitamin C supplements on urinary oxalate and pH in calcium stone-forming patients. Kidney Int 2003; 63(3): 1066-71.
[http://dx.doi.org/10.1046/j.1523-1755.2003.00815.x] [PMID: 12631089]
[52]
Curhan GC, Willett WC, Speizer F, Stampfer MJ. Intake of vitamins B6 and C and the risk of kidney stones in women. J Am Soc Nephrol 1999; 10(4): 840-5.
[http://dx.doi.org/10.1681/ASN.V104840] [PMID: 10203369]
[53]
Ticinesi A, Nouvenne A, Ferraro PM, et al. Idiophatic calcium nephrolitiasis and hypovitaminosis D: A case-control study. Urology 2016; 87: 40-5.
[http://dx.doi.org/10.1016/j.urology.2015.10.009] [PMID: 26494294]
[54]
Iguchi M, Umekawa T, Takamura C, et al. Glucose metabolism in renal stone patients. Urol Int 1993; 51(4): 185-90.
[http://dx.doi.org/10.1159/000282542] [PMID: 8266608]
[55]
Nguyen NU, Dumoulin G, Henriet MT, Berthelay S, Regnard J. Carbohydrate metabolism and urinary excretion of calcium and oxalate after ingestion of polyol sweeteners. J Clin Endocrinol Metab 1993; 77(2): 388-92.
[PMID: 8345042]
[56]
Garg A, Bonanome A, Grundy SM, Unger RH, Breslau NA, Pak CC. Effects of dietary carbohydrates on metabolism of calcium and other minerals in normal subjects and patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1990; 70(4): 1007-13.
[http://dx.doi.org/10.1210/jcem-70-4-1007] [PMID: 2156883]
[57]
Yoon V, Adams-Huet B, Sakhaee K, Maalouf NM. Hyperinsulinemia and urinary calcium excretion in calcium stone formers with idio-pathic hypercalciuria. J Clin Endocrinol Metab 2013; 98(6): 2589-94.
[http://dx.doi.org/10.1210/jc.2013-1301] [PMID: 23553859]
[58]
Baggio B, Gambaro G, Zambon S, et al. Anomalous phospholipid n-6 polyunsaturated fatty acid composition in idiopathic calcium neph-rolithiasis. J Am Soc Nephrol 1996; 7(4): 613-20.
[http://dx.doi.org/10.1681/ASN.V74613] [PMID: 8724896]
[59]
Siener R, Jansen B, Watzer B, Hesse A. Effect of n-3 fatty acid supplementation on urinary risk factors for calcium oxalate stone for-mation. J Urol 2011; 185(2): 719-24.
[http://dx.doi.org/10.1016/j.juro.2010.09.074] [PMID: 21168878]
[60]
Taylor EN, Stampfer MJ, Curhan GC. Fatty acid intake and incident nephrolithiasis. Am J Kidney Dis 2005; 45(2): 267-74.
[http://dx.doi.org/10.1053/j.ajkd.2004.09.026] [PMID: 15685503]
[61]
Escribano J, Balaguer A, Roqué i Figuls M, Feliu A, Ferre N. Dietary interventions for preventing complications in idiopathic hypercalciuria. Cochrane Libr 2014; (2): CD006022.
[http://dx.doi.org/10.1002/14651858.CD006022.pub4] [PMID: 24519664]
[62]
Devaraj S, Hemarajata P, Versalovic J. The human gut microbiome and body metabolism: Implications for obesity and diabetes. Clin Chem 2013; 59(4): 617-28.
[http://dx.doi.org/10.1373/clinchem.2012.187617] [PMID: 23401286]
[63]
Cresci GA, Bawden E. Gut Microbiome. Nutr Clin Pract 2015; 30(6): 734-46.
[http://dx.doi.org/10.1177/0884533615609899] [PMID: 26449893]
[64]
Qin J, Li R, Raes J, et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464(7285): 59-65.
[http://dx.doi.org/10.1038/nature08821] [PMID: 20203603]
[65]
Beaugerie L, Petit JC. Antibiotic-associated diarrhoea. Best Pract Res Clin Gastroenterol 2004; 18(2): 337-52.
[http://dx.doi.org/10.1016/j.bpg.2003.10.002] [PMID: 15123074]
[66]
Louis P, Flint HJ. Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine. FEMS Microbiol Lett 2009; 294(1): 1-8.
[http://dx.doi.org/10.1111/j.1574-6968.2009.01514.x] [PMID: 19222573]
[67]
Macfarlane GT, Macfarlane S. Fermentation in the human large intestine: Its physiologic consequences and the potential contribution of prebiotics. J Clin Gastroenterol 2011; 45 (Suppl.): S120-7.
[http://dx.doi.org/10.1097/MCG.0b013e31822fecfe] [PMID: 21992950]
[68]
Collins SM, Surette M, Bercik P. The interplay between the intestinal microbiota and the brain. Nat Rev Microbiol 2012; 10(11): 735-42.
[http://dx.doi.org/10.1038/nrmicro2876] [PMID: 23000955]
[69]
Biasucci G, Benenati B, Morelli L, Bessi E, Boehm G. Cesarean delivery may affect the early biodiversity of intestinal bacteria. J Nutr 2008; 138(9): 1796S-800S.
[http://dx.doi.org/10.1093/jn/138.9.1796S] [PMID: 18716189]
[70]
Penders J, Thijs C, Vink C, et al. Factors influencing the composition of the intestinal microbiota in early infancy. Pediatrics 2006; 118(2): 511-21.
[http://dx.doi.org/10.1542/peds.2005-2824] [PMID: 16882802]
[71]
Harmsen HJM, Wildeboer-Veloo ACM, Raangs GC, et al. Analysis of intestinal flora development in breast-fed and formula-fed infants by using molecular identification and detection methods. J Pediatr Gastroenterol Nutr 2000; 30(1): 61-7.
[http://dx.doi.org/10.1097/00005176-200001000-00019] [PMID: 10630441]
[72]
Roger LC, Costabile A, Holland DT, Hoyles L, McCartney AL. Examination of faecal Bifidobacterium populations in breast- and formula-fed infants during the first 18 months of life. Microbiology (Reading) 2010; 156(11): 3329-41.
[http://dx.doi.org/10.1099/mic.0.043224-0] [PMID: 20864478]
[73]
Fujimura KE, Demoor T, Rauch M, et al. House dust exposure mediates gut microbiome Lactobacillus enrichment and airway immune defense against allergens and virus infection. Proc Natl Acad Sci USA 2014; 111(2): 805-10.
[http://dx.doi.org/10.1073/pnas.1310750111] [PMID: 24344318]
[74]
Bergström A, Skov TH, Bahl MI, et al. Establishment of intestinal microbiota during early life: A longitudinal, explorative study of a large cohort of Danish infants. Appl Environ Microbiol 2014; 80(9): 2889-900.
[http://dx.doi.org/10.1128/AEM.00342-14] [PMID: 24584251]
[75]
Mariat D, Firmesse O, Levenez F, et al. The Firmicutes/Bacteroidetes ratio of the human microbiota changes with age. BMC Microbiol 2009; 9(1): 123.
[http://dx.doi.org/10.1186/1471-2180-9-123] [PMID: 19508720]
[76]
Hidaka H, Eida T, Takizawa T, Tokunaga T, Tashiro Y. Effects of fruttoligosaccharides on intestinal flora and human health. Bifidobact Microflora 1986; 5(1): 37-50.
[http://dx.doi.org/10.12938/bifidus1982.5.1_37]
[77]
D’Argenio V, Salvatore F. The role of the gut microbiome in the healthy adult status. Clin Chim Acta 2015; 451((Pt A)): 97-102.
[http://dx.doi.org/10.1016/j.cca.2015.01.003] [PMID: 25584460]
[78]
De Filippo C, Cavalieri D, Di Paola M, et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc Natl Acad Sci USA 2010; 107(33): 14691-6.
[http://dx.doi.org/10.1073/pnas.1005963107] [PMID: 20679230]
[79]
Monira S, Nakamura S, Gotoh K, et al. Gut microbiota of healthy and malnourished children in bangladesh. Front Microbiol 2011; 2: 228.
[http://dx.doi.org/10.3389/fmicb.2011.00228] [PMID: 22125551]
[80]
Riordan SM, McIver CJ, Wakefield D, Duncombe VM, Thomas MC, Bolin TD. Small intestinal mucosal immunity and morphometry in luminal overgrowth of indigenous gut flora. Am J Gastroenterol 2001; 96(2): 494-500.
[http://dx.doi.org/10.1111/j.1572-0241.2001.03533.x] [PMID: 11232696]
[81]
Vedantam G, Hecht DW. Antibiotics and anaerobes of gut origin. Curr Opin Microbiol 2003; 6(5): 457-61.
[http://dx.doi.org/10.1016/j.mib.2003.09.006] [PMID: 14572537]
[82]
Bode L. Human milk oligosaccharides: Every baby needs a sugar mama. Glycobiology 2012; 22(9): 1147-62.
[http://dx.doi.org/10.1093/glycob/cws074] [PMID: 22513036]
[83]
Wu GD, Chen J, Hoffmann C, et al. Linking long-term dietary patterns with gut microbial enterotypes. Science 2011; 334(6052): 105-8.
[http://dx.doi.org/10.1126/science.1208344] [PMID: 21885731]
[84]
Walker AW, Ince J, Duncan SH, et al. Dominant and diet-responsive groups of bacteria within the human colonic microbiota. ISME J 2011; 5(2): 220-30.
[http://dx.doi.org/10.1038/ismej.2010.118] [PMID: 20686513]
[85]
Claesson MJ, Jeffery IB, Conde S, et al. Gut microbiota composition correlates with diet and health in the elderly. Nature 2012; 488(7410): 178-84.
[http://dx.doi.org/10.1038/nature11319] [PMID: 22797518]
[86]
Le Chatelier E, Nielsen T, Qin J, et al. Richness of human gut microbiome correlates with metabolic markers. Nature 2013; 500(7464): 541-6.
[http://dx.doi.org/10.1038/nature12506] [PMID: 23985870]
[87]
Zimmer J, Lange B, Frick J-S, et al. A vegan or vegetarian diet substantially alters the human colonic faecal microbiota. Eur J Clin Nutr 2012; 66(1): 53-60.
[http://dx.doi.org/10.1038/ejcn.2011.141] [PMID: 21811294]
[88]
Lyte M, Vulchanova L, Brown DR. Stress at the intestinal surface: Catecholamines and mucosa–bacteria interactions. Cell Tissue Res 2011; 343(1): 23-32.
[http://dx.doi.org/10.1007/s00441-010-1050-0] [PMID: 20941511]
[89]
De Palma G, Collins SM, Bercik P, Verdu EF. The microbiota-gut-brain axis in gastrointestinal disorders: Stressed bugs, stressed brain or both? J Physiol 2014; 592(14): 2989-97.
[http://dx.doi.org/10.1113/jphysiol.2014.273995] [PMID: 24756641]
[90]
Bercik P, Park AJ, Sinclair D, et al. The anxiolytic effect of Bifidobacterium longum NCC3001 involves vagal pathways for gut-brain communication. Neurogastroenterol Motil 2011; 23(12): 1132-9.
[http://dx.doi.org/10.1111/j.1365-2982.2011.01796.x] [PMID: 21988661]
[91]
Dethlefsen L, Huse S, Sogin ML, Relman DA. The pervasive effects of an antibiotic on the human gut microbiota, as revealed by deep 16S rRNA sequencing. PLoS Biol 2008; 6(11): e280.
[http://dx.doi.org/10.1371/journal.pbio.0060280] [PMID: 19018661]
[92]
Dethlefsen L, Relman DA. Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation. Proc Natl Acad Sci USA 2011; 108 (Suppl. 1): 4554-61.
[http://dx.doi.org/10.1073/pnas.1000087107] [PMID: 20847294]
[93]
Shaw SY, Blanchard JF, Bernstein CN. Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease. Am J Gastroenterol 2010; 105(12): 2687-92.
[http://dx.doi.org/10.1038/ajg.2010.398] [PMID: 20940708]
[94]
Virta L, Auvinen A, Helenius H, Huovinen P, Kolho KL. Association of repeated exposure to antibiotics with the development of pediatric Crohn’s disease--a nationwide, register-based finnish case-control study. Am J Epidemiol 2012; 175(8): 775-84.
[http://dx.doi.org/10.1093/aje/kwr400] [PMID: 22366379]
[95]
Trasande L, Blustein J, Liu M, Corwin E, Cox LM, Blaser MJ. Infant antibiotic exposures and early-life body mass. Int J Obes 2013; 37(1): 16-23.
[http://dx.doi.org/10.1038/ijo.2012.132] [PMID: 22907693]
[96]
Stensballe LG, Simonsen J, Jensen SM, Bønnelykke K, Bisgaard H. Use of antibiotics during pregnancy increases the risk of asthma in early childhood. J Pediatr 2013; 162(4): 832-838.e3.
[http://dx.doi.org/10.1016/j.jpeds.2012.09.049] [PMID: 23140881]
[97]
De La Cochetière MF, Durand T, Lepage P, Bourreille A, Galmiche JP, Doré J. Resilience of the dominant human fecal microbiota upon short-course antibiotic challenge. J Clin Microbiol 2005; 43(11): 5588-92.
[http://dx.doi.org/10.1128/JCM.43.11.5588-5592.2005] [PMID: 16272491]
[98]
Hesse A, Siener R. Current aspects of epidemiology and nutrition in urinary stone disease. World J Urol 1997; 15(3): 165-71.
[http://dx.doi.org/10.1007/BF02201853] [PMID: 9228723]
[99]
Holmes RP, Goodman HO, Assimos DG. Contribution of dietary oxalate to urinary oxalate excretion. Kidney Int 2001; 59(1): 270-6.
[http://dx.doi.org/10.1046/j.1523-1755.2001.00488.x] [PMID: 11135080]
[100]
Taylor EN, Curhan GC. Determinants of 24-hour urinary oxalate excretion. Clin J Am Soc Nephrol 2008; 3(5): 1453-60.
[http://dx.doi.org/10.2215/CJN.01410308] [PMID: 18650406]
[101]
Holmes RP, Assimos DG. Glyoxylate synthesis, and its modulation and influence on oxalate synthesis. J Urol 1998; 160(5): 1617-24.
[http://dx.doi.org/10.1016/S0022-5347(01)62363-2] [PMID: 9783918]
[102]
Williams HE, Wandzilak TR. Oxalate synthesis, transport and the hyperoxaluric syndromes. J Urol 1989; 141(3 Pt 2): 742-7.
[http://dx.doi.org/10.1016/S0022-5347(17)40999-2] [PMID: 2645433]
[103]
Hokama S, Toma C, Iwanaga M, Morozumi M, Sugaya K, Ogawa Y. Oxalate-degrading Providencia rettgeri isolated from human stools. Int J Urol 2005; 12(6): 533-8.
[http://dx.doi.org/10.1111/j.1442-2042.2005.01083.x] [PMID: 15985073]
[104]
Conyers RA, Bais R, Rofe AM. The relation of clinical catastrophes, endogenous oxalate production, and urolithiasis. Clin Chem 1990; 36(10): 1717-30.
[http://dx.doi.org/10.1093/clinchem/36.10.1717] [PMID: 2208646]
[105]
Hodgkinson A. Oxalic acid in biology and medicine. Academic Press 1977.
[106]
Sidhu H, Schmidt ME, Cornelius JG, et al. Direct correlation between hyperoxaluria/oxalate stone disease and the absence of the gastroin-testinal tract-dwelling bacterium Oxalobacter formigenes: Possible prevention by gut recolonization or enzyme replacement therapy. J Am Soc Nephrol 1999; 10 (Suppl. 14): S334-40.
[PMID: 10541258]
[107]
Allison MJ, Cook HM, Milne DB, Gallagher S, Clayman RV. Oxalate degradation by gastrointestinal bacteria from humans. J Nutr 1986; 116(3): 455-60.
[http://dx.doi.org/10.1093/jn/116.3.455] [PMID: 3950772]
[108]
Allison MJ, Dawson KA, Mayberry WR, Foss JG. Oxalobacter formigenes gen. nov., sp. nov.: Oxalate-degrading anaerobes that inhabit the gastrointestinal tract. Arch Microbiol 1985; 141(1): 1-7.
[http://dx.doi.org/10.1007/BF00446731] [PMID: 3994481]
[109]
Mehta M, Goldfarb DS, Nazzal L. The role of the microbiome in kidney stone formation. Int J Surg 2016; 36(Pt D): 607-12.
[http://dx.doi.org/10.1016/j.ijsu.2016.11.024] [PMID: 27847292]
[110]
Sidhu H, Enatska L, Ogden S, Williams W, Allison M, Peck A. Evaluating children in the Ukraine for colonization with the intestinal bacte-rium Oxalobacter formigenes, using a polymerase chain reactionbased detection system. Mol Diagn 1997; 2(2): 89-97.
[http://dx.doi.org/10.1016/S1084-8592(97)80015-X] [PMID: 10462596]
[111]
Kumar R, Mukherjee M, Bhandari M, Kumar A, Sidhu H, Mittal RD. Role of Oxalobacter formigenes in calcium oxalate stone disease: A study from North India. Eur Urol 2002; 41(3): 318-22.
[http://dx.doi.org/10.1016/S0302-2838(02)00040-4] [PMID: 12180235]
[112]
Kaufman DW, Kelly JP, Curhan GC, et al. Oxalobacter formigenes may reduce the risk of calcium oxalate kidney stones. J Am Soc Nephrol 2008; 19(6): 1197-203.
[http://dx.doi.org/10.1681/ASN.2007101058] [PMID: 18322162]
[113]
Duncan SH, Richardson AJ, Kaul P, Holmes RP, Allison MJ, Stewart CS. Oxalobacter formigenes and its potential role in human health. Appl Environ Microbiol 2002; 68(8): 3841-7.
[http://dx.doi.org/10.1128/AEM.68.8.3841-3847.2002] [PMID: 12147479]
[114]
Sidhu H, Hoppe B, Hesse A, et al. Absence of Oxalobacter formigenes in cystic fibrosis patients: A risk factor for hyperoxaluria. Lancet 1998; 352(9133): 1026-9.
[http://dx.doi.org/10.1016/S0140-6736(98)03038-4] [PMID: 9759746]
[115]
Sidhu H, Allison MJ, Chow JOM, Clark A, Peck AB. Rapid reversal of hyperoxaluria in a rat model after probiotic administration of Oxalobacter formigenes. J Urol 2001; 166(4): 1487-91.
[http://dx.doi.org/10.1016/S0022-5347(05)65817-X] [PMID: 11547118]
[116]
Siener R, Ebert D, Hesse A. Urinary oxalate excretion in female calcium oxalate stone formers with and without a history of recurrent urinary tract infections. Urol Res 2001; 29(4): 245-8.
[http://dx.doi.org/10.1007/s002400100198] [PMID: 11585279]
[117]
Troxel SA, Sidhu H, Kaul P, Low RK. Intestinal Oxalobacter formigenes colonization in calcium oxalate stone formers and its relation to urinary oxalate. J Endourol 2003; 17(3): 173-6.
[http://dx.doi.org/10.1089/089277903321618743] [PMID: 12803990]
[118]
Kwak C, Kim HK, Kim EC, Choi MS, Kim HH. Urinary oxalate levels and the enteric bacterium Oxalobacter formigenes in patients with calcium oxalate urolithiasis. Eur Urol 2003; 44(4): 475-81.
[http://dx.doi.org/10.1016/S0302-2838(03)00318-X] [PMID: 14499684]
[119]
Mittal RD, Kumar R. Gut-inhabiting bacterium Oxalobacter formigenes: Role in calcium oxalate urolithiasis. J Endourol 2004; 18(5): 418-24.
[http://dx.doi.org/10.1089/0892779041271706] [PMID: 15253809]
[120]
Prokopovich S, Knight J, Assimos DG, Holmes RP. Variability of Oxalobacter formigenes and oxalate in stool samples. J Urol 2007; 178(5): 2186-90.
[http://dx.doi.org/10.1016/j.juro.2007.06.045] [PMID: 17870112]
[121]
Magwira CA, Kullin B, Lewandowsky A, et al. Diversity of faecal oxalate-degrading bacteria in black and white South African study groups: insight into understanding the rariry of urolithiasis in the black group. J Appl Microbiol 2012; 113: 418-28.
[122]
Ito H, Miura N, Masai M, Yamamoto K, Hara T. Reduction of oxalate content of foods by the oxalate degrading bacterium, Eubacterium lentum WYH-1. Int J Urol 1996; 3(1): 31-4.
[http://dx.doi.org/10.1111/j.1442-2042.1996.tb00626.x] [PMID: 8646596]
[123]
Miller AW, Kohl KD, Dearing MD. Microenvironments of the gut harbor distinct consortia of oxalate-degrading bacteria. Appl Environ Microbiol 2013; 2: 636-52.
[124]
Hokama S, Honma Y, Toma C, Ogawa Y. Oxalate-Degrading Enterococcus faecalis. Microbiol Immunol 2000; 44(4): 235-40.
[http://dx.doi.org/10.1111/j.1348-0421.2000.tb02489.x] [PMID: 10832966]
[125]
Campieri C, Campieri M, Bertuzzi V, et al. Reduction of oxaluria after an oral course of lactic acid bacteria at high concentration. Kidney Int 2001; 60(3): 1097-105.
[http://dx.doi.org/10.1046/j.1523-1755.2001.0600031097.x] [PMID: 11532105]
[126]
Turroni S, Vitali B, Bendazzoli C, et al. Oxalate consumption by lactobacilli: Evaluation of oxalyl-CoA decarboxylase and formyl-CoA transferase activity in Lactobacillus acidophilus. J Appl Microbiol 2007; 103(5): 1600-9.
[http://dx.doi.org/10.1111/j.1365-2672.2007.03388.x] [PMID: 17953571]
[127]
Turroni S, Bendazzoli C, Dipalo SCF, et al. Oxalate-degrading activity in Bifidobacterium animalis subsp. lactis: Impact of acidic condi-tions on the transcriptional levels of the oxalyl coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes. Appl Environ Microbiol 2010; 76(16): 5609-20.
[http://dx.doi.org/10.1128/AEM.00844-10] [PMID: 20601517]
[128]
Azcarate-Peril MA, Bruno-Bárcena JM, Hassan HM, Klaenhammer TR. Transcriptional and functional analysis of oxalyl-coenzyme A (CoA) decarboxylase and formyl-CoA transferase genes from Lactobacillus acidophilus. Appl Environ Microbiol 2006; 72(3): 1891-9.
[http://dx.doi.org/10.1128/AEM.72.3.1891-1899.2006] [PMID: 16517636]
[129]
Miller A, Dearing D. The metabolic and ecological interactions of oxalate-degrading bacteria in the Mammalian gut. Pathogens 2013; 2(4): 636-52.
[http://dx.doi.org/10.3390/pathogens2040636] [PMID: 25437337]
[130]
Hoppe B, Groothoff JW, Hulton SA, et al. Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxalu-ria. Nephrol Dial Transplant 2011; 26(11): 3609-15.
[http://dx.doi.org/10.1093/ndt/gfr107] [PMID: 21460356]
[131]
Goldfarb DS, Modersitzki F, Asplin JR. A randomized, controlled trial of lactic acid bacteria for idiopathic hyperoxaluria. Clin J Am Soc Nephrol 2007; 2(4): 745-9.
[http://dx.doi.org/10.2215/CJN.00600207] [PMID: 17699491]
[132]
Siener R, Bangen U, Sidhu H, Hönow R, von Unruh G, Hesse A. The role of Oxalobacter formigenes colonization in calcium oxalate stone disease. Kidney Int 2013; 83(6): 1144-9.
[http://dx.doi.org/10.1038/ki.2013.104] [PMID: 23536130]
[133]
De Lorenzo A, Gratteri S, Gualtieri P, Cammarano A, Bertucci P, Di Renzo L. Why primary obesity is a disease? J Transl Med 2019; 17(1): 169.
[http://dx.doi.org/10.1186/s12967-019-1919-y] [PMID: 31118060]
[134]
Lorenzo AD, Soldati L, Sarlo F, Calvani M, Di Lorenzo N, Di Renzo L. New obesity classification criteria as a tool for bariatric surgery indication. World J Gastroenterol 2016; 22(2): 681-703.
[http://dx.doi.org/10.3748/wjg.v22.i2.681] [PMID: 26811617]
[135]
De Lorenzo A, Romano L, Di Renzo L, Di Lorenzo N, Cenname G, Gualtieri P. Obesity: A preventable, treatable, but relapsing disease. Nutrition 2020; 71: 110615.
[http://dx.doi.org/10.1016/j.nut.2019.110615] [PMID: 31864969]
[136]
Di Renzo L, Gualtieri P, Romano L, et al. Role of personalized nutrition in Chronic-degenerative diseases. Nutrients 2019; 11(8): 1707.
[http://dx.doi.org/10.3390/nu11081707] [PMID: 31344895]
[137]
Di Renzo L, Gualtieri P, Pivari F, et al. COVID-19: Is there a role for immunonutrition in obese patient? J Transl Med 2020; 18(1): 415.
[http://dx.doi.org/10.1186/s12967-020-02594-4] [PMID: 33160363]
[138]
Marzullo P, Di Renzo L, Pugliese G, et al. From obesity through gut microbiota to cardiovascular diseases: A dangerous journey. Int J Obes Suppl 2020; 10(1): 35-49.
[http://dx.doi.org/10.1038/s41367-020-0017-1] [PMID: 32714511]
[139]
Di Renzo L, Franza L, Monsignore D, et al. vaccines, microbiota and immunonutrition: Food for thought. Vaccines (Basel) 2022; 10(2): 294.
[http://dx.doi.org/10.3390/vaccines10020294] [PMID: 35214752]
[140]
De Lorenzo A, Cenname G, Marchetti M, et al. Social inequalities and nutritional disparities: The link between obesity and COVID-19. Eur Rev Med Pharmacol Sci 2022; 26(1): 320-39.
[http://dx.doi.org/10.26355/eurrev_202201_27784] [PMID: 35049011]
[141]
Soldati L, Di Renzo L, Jirillo E, Ascierto PA, Marincola FM, De Lorenzo A. The influence of diet on anti-cancer immune responsiveness. J Transl Med 2018; 16(1): 75.
[http://dx.doi.org/10.1186/s12967-018-1448-0] [PMID: 29558948]
[142]
Colica C, Avolio E, Bollero P, et al. Evidences of a new psychobiotic formulation on body composition and anxiety. Mediators Inflamm 2017; 2017: 1-10.
[http://dx.doi.org/10.1155/2017/5650627] [PMID: 29147070]
[143]
De Lorenzo A, Costacurta M, Merra G, et al. Can psychobiotics intake modulate psychological profile and body composition of women affected by normal weight obese syndrome and obesity? A double blind randomized clinical trial. J Transl Med 2017; 15(1): 135.
[http://dx.doi.org/10.1186/s12967-017-1236-2] [PMID: 28601084]

Rights & Permissions Print Cite
Article Metrics
15
2
Wayfinder Image
International Day of People with Disability
© 2024 Bentham Science Publishers | Privacy Policy